DMIIDrugs Made In America Acquisition II Corp.
10.14USD0.00%Mkt Cap: 645.92M $P/E: 34.971d ago
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other si…
Industry Peers
Shell Companies$813.22MUSD
$601.52MUSD
$594.94MUSD
CEPF
Cantor Equity Partners IV Inc. Class A Ordinary Shares$593.79MUSDP/E 28.1
AEXA
American Exceptionalism Acquisition Corp. A$574.73MUSD
$555.37MUSD
VACH
Voyager Acquisition Corp Class A Ordinary Shares$541.25MUSDP/E 81.5
$514.21MUSD
$506.47MUSD
MEVO
M Evo Global Acquisition Corp II Class A Ordinary Shares$498.00MUSD
$485.33MUSD
$480.90MUSD
GTEN
Gores Holdings X Inc. Class A ordinary shares$480.72MUSDP/E 7.0
$476.13MUSDP/E 52.1
$475.57MUSD
$465.12MUSD
IEAG
Infinite Eagle Acquisition Corp. Class A Ordinary Shares$446.52MUSD
KBON
Karbon Capital Partners Corp. Class A Ordinary Shares$444.55MUSD
$440.74MUSD
IACO
Idea Acquisition Corp. Class A Ordinary Shares$436.19MUSD
| Headline | Source | Time |
|---|---|---|
Older | ||
 NexGen Energy’s Rook I Project Emerges as a Key Source in the Next Uranium Supply Wave MMCAP International increased its stake in NexGen Energy during the fourth quarter, deepening exposure to the company’s Rook I uranium project in Canada. As governments extend reactor lifespans and reconsider nuclear expansion, attention is turning to future uranium supply and how quickly projects like Rook I can begin production. | ||
 Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) is largely controlled by institutional shareholders who own 79% of the company Key Insights Institutions' substantial holdings in Drugs Made In America Acquisition II implies that they have... | ||